Straumann Holding AG (OTCMKTS:SAUHY) Receives Consensus Rating of “Hold” from Brokerages

Shares of Straumann Holding AG (OTCMKTS:SAUHY) have received a consensus rating of “Hold” from the seven brokerages that are covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company.

SAUHY has been the topic of a number of recent research reports. Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a report on Tuesday, June 30th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Straumann in a research report on Tuesday, June 30th. BMO Capital Markets assumed coverage on Straumann in a report on Wednesday. They set an “outperform” rating on the stock. Barclays reiterated an “overweight” rating on shares of Straumann in a research report on Thursday, June 18th. Finally, Citigroup reissued a “sell” rating on shares of Straumann in a research note on Thursday.

Straumann Price Performance

SAUHY opened at $13.03 on Monday. Straumann has a fifty-two week low of $9.44 and a fifty-two week high of $14.11. The company’s 50 day moving average price is $11.97 and its two-hundred day moving average price is $11.65.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.